AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Inflazyme to acquire Adprotech Ltd; gains new inflammation research technology and clinical programme.
(From Chemical Business NewsBase - Press Release)
Inflazyme Pharmaceuticals Ltd (Inflazyme) and Adprotech Ltd, have entered into an agreement whereby, subject to necessary regulatory approvals, Inflazyme will acquire Adprotech. Inflazyme will issue about 12.7 M common shares to acquire all outstanding Adprotech shares in a deal valued at about C$ 20 M. The acquisition will give Inflazyme a new inflammation technology platform, complement inhibition, and a potential novel clinical compound being developed for the treatment of rheumatoid arthritis. The acquisition of Adprotech will further strengthen Inflazyme's position as a leader in the development of novel anti-inflammatory therapies by adding a new, innovative, technology platform, complement inhibition, to its portfolio. Inflazyme will issue about 12.7 M common shares in exchange for all of the issued and outstanding ...
- Inflazyme to Acquire Adprotech Limited; Gains New Inflammation Research...
- Press release article from: Business Wire April 7, 2004 700+ words
...Inflazyme will acquire Adprotech. Inflazyme will issue approximately...inhibition. The acquisition of Adprotech gives Inflazyme access to a new approach...Boards of Directors of both Adprotech and Inflazyme. Following the completion...
- Adprotech Being Acquired By Inflazyme In C$20M Deal.(Inflazyme Pharmaceuticals...
- Magazine article from: BIOWORLD Today Moran, Nuala April 13, 2004 700+ words
...The acquisition of Adprotech by Inflazyme, of Vancouver, British...Adprotech, giving Adprotech investors 12 percent of Inflazyme. Inflazyme's shares...clear what investment Inflazyme will make in Adprotech's programs going...
- Adprotech Being Acquired By Inflazyme In C$20M Deal.
- Magazine article from: BIOWORLD Today November 3, 2009 700+ words
...The acquisition of Adprotech by Inflazyme, of Vancouver, British...Adprotech, giving Adprotech investors 12 percent of Inflazyme. Inflazyme's shares...clear what investment Inflazyme will make in Adprotech's programs going...
- Inflazyme Completes Acquisition of Adprotech Ltd.
- News wire article from: Canadian Corporate News April 21, 2004 700+ words
...completed their acquisition of Adprotech Ltd. Inflazyme issued approximately 12...outstanding shares of Adprotech. Adprotech shareholders will now hold...12% of the outstanding Inflazyme common shares. Adprotech shareholders have agreed...
- Inflazyme Pharmaceuticals Announces Re-Aligned R&D Strategy Undertaking...
- Press release article from: Business Wire July 28, 2004 700+ words
...recent acquisition of Adprotech. The Company will...comprising people from both Inflazyme and Adprotech. The Company will...our acquisition of Adprotech. Prudence dictates...earlier milestones". Inflazyme's Revised R&...
- Inflazyme Dropping 'Not Core' GH9001 Due To Liver Enzymes.
- Magazine article from: BIOWORLD Today November 3, 2009 700+ words
...expected this summer. Inflazyme intends to transfer...s acquisition of Adprotech Ltd., of Cambridge...experiencing a disease flare. Inflazyme acquired Adprotech last month for about...April 13, 2004.) Inflazyme acquired GlycoDesign...
- INFLAZYME DROPPING 'NOT CORE' GH9001 DUE TO LIVER ENZYMES.
- Magazine article from: BIOWORLD Today Pihl-Carey, Karen May 17, 2004 700+ words
...expected this summer. Inflazyme intends to transfer...s acquisition of Adprotech Ltd., of Cambridge...experiencing a disease flare. Inflazyme acquired Adprotech last month for about...April 13, 2004.) Inflazyme acquired GlycoDesign...
- Inflazyme not to Progress Further Development of GH9001; Resources Directed to...
- News wire article from: Canadian Corporate News May 13, 2004 700+ words
...by Inflazyme scientists. Inflazyme's lead LSAID(TM), IPL512...2004. On April 20, 2004, Inflazyme announced that it had acquired Adprotech Limited, a Cambridge, UK...expected by the end of 2004. Inflazyme is a Vancouver based biopharmaceutical...